Short-term treatment of CIDP with efgartigimod: a case series in China

Short-term treatment of CIDP with efgartigimod: a case series in China

ObjectiveChronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a type of autoimmune neuropathy with treatment challenges due to the limitations of standard of care therapies. Efgartigimod, a neonatal Fc receptor antagonist, has shown potential in treating antibody-mediated disorders in...

Full description

Saved in:
Bibliographic Details
Main Authors: Chong Sun, Jianian Hu, Yanyin Zhao, Yongsheng Zheng, Quanhua Meng, Sushan Luo, Kai Qiao, Jian Sun, Jiahong Lu, Jie Lin, Chongbo Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Immunology
Subjects:
chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
efgartigimod
short-term
treatment
real-world study
China
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1533167/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items